PA-BENTLEY-SYSTEMS
1.12.2021 22:03:10 CET | Business Wire | Press release
Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced the Year in Infrastructure 2021 Founders’ Honorees. During the 2021 Year in Infrastructure and Going Digital Awards virtual event today, 22 Founders’ Honorees were recognized, representing organizations or individuals whose undertakings contribute notably to infrastructure advancement and/or environmental/social development goals.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211201006051/en/
Bentley Systems founders Keith and Greg Bentley, and Bentley’s Director of ES(D)G Rodrigo Fernandes, reviewed the compelling credentials of 18 Honorees selected from 230 organizations who submitted nominations for the company’s annual Going Digital Awards in Infrastructure program. Chief Acceleration Officer Santanu Das recognized three Honoree organizations respectively for Infrastructure IoT , iTwin Enterprise , and iTwin Entrepreneur . Nick Smallwood, CEO, on behalf of the U.K.’s Infrastructure and Projects Authority, was honored for ES(D)G Advocacy .
The Year in Infrastructure 2021 Founders’ Honorees are:
ES(D)G Honoree for Affordable and Clean Energy
Fujian Yongfu Power Engineering Co., Ltd.
Fujian Changle Zone C Offshore Wind Farm
Changle/Fuzhou, Fujian, China
ES(D)G Honoree for Climate Action
Evides NV
Pumping Energy Optimization and CO2 Reduction Evides Case Study
Rotterdam, Netherlands
ES(D)G Honoree for Sustainable Cities and Communities
GenMap
Tree Modeling and Feature Extraction Using Mobile Mapping
Mendoza, Argentina
For 4D Design Review
PT MRT Jakarta (Perseroda)
MRT Jakarta Phase II
Jakarta, Indonesia
For 4D Digital Twins Advancement
WSB
TH 169: Redefine Elk River
Elk River, Minnesota, United States
For As-Operated Digital Twin
CNOOC Energy Development Design and R&D Center
Digital Twin Project of the FPSO Offshore Oil Gathering and Transportation Platform
South China Sea, Guangdong, China
For Collaborative Success
Wood
Wood Bentley Digital Community Collaborative Portal
United Kingdom
For Comprehensive Collaboration
CES_SDC Pte Ltd & AECOM Singapore Pte Ltd
Tuas Water Reclamation Plant - Contract C4A - BioSolids & Digesters
Singapore
For Comprehensive Project Digital Twin
China Railway First Survey and Design Institute Group Co., Ltd.
Application of BIM Technology in the Design of Xi’an-Shiyan High-Speed Railway
Xi’an, Lantian, Shangluo, Shanyang, and Shiyan; Shaanxi and Hubei; China
For Digital Adaptation
AFRY & Tyréns Consortium
East Link
Stockholm, Sweden
For Digital Integrator
Mott MacDonald and National Grid
London Power Tunnels 2
London, United Kingdom
For Digital Twins R&D
Shanghai Investigation, Design & Research Institute Co., Ltd.
The Application of Digital Twin Technology in the Full Lifecycle of Offshore Wind Power Projects
Beijing, China
For ES(D)G Advocacy
Nick Smallwood (on behalf of Infrastructure and Projects Authority)
Infrastructure and Projects Authority
United Kingdom
For Global Future-proofing
Brigantium Engineering
ITER: In-Pit Activities for Tokamak Assembly
St. Paul-les-Durance, Bouches-du-Rhone, France
For Going Digital in Education
Center for Industrial Technological Studies and Services No. 33
CETIS 33 BIM Workshop
Mexico City, Mexico
For Infrastructure IoT
GZA GeoEnvironmental
United States
For iTwin Enterprise
Consilience Analytics
United States
For iTwin Entrepreneur
SewerAI
United States
For National Digital Twin
Singapore Land Authority
Advancing Singapore National 3D Reality Mapping for a Changing World
Singapore
For Pandemic-proof Execution
PT Hutama Karya (Persero)
Modification of Surabaya - Gresik Toll Road Interchange
Surabaya, East Java, Indonesia
For Project Delivery Visibility
Zachry Industrial, Inc., a Zachry Group Company
Golden Pass LNG Export Project
Sabine Pass, Texas, United States
For Virtuoso Invention
NP Singh
GMW Pvt. Ltd.
India
To view the project descriptions and access the images, visit the Founders’ Honorees webpage. Detailed descriptions of all nominated projects will be published in the print and digital versions of Bentley’s 2021 Infrastructure Yearbook in early 2022. To review the past editions of this publication, access Bentley’s Infrastructure Yearbooks .
Watch the executive sessions and the Going Digital Awards finalists’ presentations from the 2021 Year in Infrastructure and Going Digital Awards virtual event on-demand here.
# #
About Bentley Systems
Bentley Systems (Nasdaq: BSY) is the infrastructure engineering software company. We provide innovative software to advance the world’s infrastructure – sustaining both the global economy and environment. Our industry-leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campuses, mining, and industrial facilities. Our offerings include MicroStation -based applications for modeling and simulation, ProjectWise for project delivery, AssetWise for asset and network performance, Seequent’s leading geosciences software portfolio, and the iTwin platform for infrastructure digital twins. Bentley Systems employs more than 4,000 colleagues and generates annual revenues of more than $800 million in 172 countries.
© 2021 Bentley Systems, Incorporated. Bentley, the Bentley logo, AssetWise, iTwin, MicroStation, ProjectWise, and Seequent are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211201006051/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom